NCT07177066View on ClinicalTrials.gov

A Study of EDG-15400 in Healthy Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Healthy Adults
Interventions
DRUG

EDG-15400

EDG-15400 is administered orally

DRUG

Placebo

Placebo is administered orally

Trial Locations (1)

85283

RECRUITING

Celerion, Inc., Tempe

Sponsors
All Listed Sponsors
lead

Edgewise Therapeutics, Inc.

INDUSTRY